Trial intelligence / Profile preview

Hy-ter lid wipes vs baby shampoo in seborrheic blepharitis

NCT04441528Phase 4Completed

Sponsor
Istanbul University-Cerrahpaşa
Start
Nov 2018
Primary completion
Nov 2019
Modality
Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Hy-ter in Seborrheic Blepharitis, sponsored by Istanbul University-Cerrahpaşa. Primary endpoint: Blepharitis Symptom measure at 12 weeks. Started Nov 2018; status: completed.

02

Drugs

Hy-ter
03

Conditions

Seborrheic Blepharitis

Beyond the preview

Go deeper on NCT04441528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04441528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call